{
  "DOI": "10.1007/s10689-021-00276-8",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-021-00276-8",
  "alternative-id": [
    "276"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "12 April 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "12 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "21 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Date",
      "name": "change_date",
      "order": 4,
      "value": "28 October 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Type",
      "name": "change_type",
      "order": 5,
      "value": "Correction"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 6,
      "value": "A Correction to this paper has been published:"
    },
    {
      "URL": "https://doi.org/10.1007/s10689-021-00279-5",
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 7,
      "value": "https://doi.org/10.1007/s10689-021-00279-5"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors have no relevant financial or non-financial interests to disclose."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the University of Michigan Institutional Review Board (IRB HUM00043430)."
    },
    {
      "group": {
        "label": "Consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Informed consent was obtained from all individual participants included in the study."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 5,
      "value": "Not applicable; no identifying information included in this report or associated dataset, figures, or tables."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-9391-3471",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Dettwyler",
      "given": "Shenin A.",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-9775-6327",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Koeppe",
      "given": "Erika S.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-0458-1952",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Jacobs",
      "given": "Michelle F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Stoffel",
      "given": "Elena M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        9,
        21
      ]
    ],
    "date-time": "2021-09-21T02:36:10Z",
    "timestamp": 1632191770000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        9
      ]
    ],
    "date-time": "2023-11-09T03:10:08Z",
    "timestamp": 1699499408000
  },
  "funder": [
    {
      "DOI": "10.13039/100000009",
      "award": [
        "P30CA046592"
      ],
      "doi-asserted-by": "publisher",
      "name": "Foundation for the National Institutes of Health"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        17
      ]
    ],
    "date-time": "2023-11-17T16:24:19Z",
    "timestamp": 1700238259906
  },
  "is-referenced-by-count": 4,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2021,
        9,
        21
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2022,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            9,
            21
          ]
        ],
        "date-time": "2021-09-21T00:00:00Z",
        "timestamp": 1632182400000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            9,
            21
          ]
        ],
        "date-time": "2021-09-21T00:00:00Z",
        "timestamp": 1632182400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00276-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-021-00276-8/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00276-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "375-385",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        9,
        21
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        9,
        21
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s10689-013-9637-8",
      "author": "CR Boland",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "journal-title": "Fam Cancer",
      "key": "276_CR1",
      "unstructured": "Boland CR, Lynch HT (2013) The history of Lynch syndrome. Fam Cancer 12:145–157. https://doi.org/10.1007/s10689-013-9637-8",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s11864-017-0468-y",
      "author": "A Afghahi",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "journal-title": "Curr Treat Options Oncol",
      "key": "276_CR2",
      "unstructured": "Afghahi A, Kurian AW (2017) The changing landscape of genetic testing for inherited breast cancer predisposition. Curr Treat Options Oncol 18:27. https://doi.org/10.1007/s11864-017-0468-y",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.14694/EDBK_160391",
      "author": "F Lynce",
      "doi-asserted-by": "publisher",
      "first-page": "72",
      "journal-title": "Am Soc Clin Oncol Educ Book",
      "key": "276_CR3",
      "unstructured": "Lynce F, Isaacs C (2016) How far do we go with genetic evaluation? Gene, panel, and tumor testing. Am Soc Clin Oncol Educ Book 35:72–78. https://doi.org/10.14694/EDBK_160391",
      "volume": "35",
      "year": "2016"
    },
    {
      "DOI": "10.1097/AOG.0000000000003562",
      "author": "TA College of Obstetricians and Gynecologists Committee on Genetics",
      "doi-asserted-by": "publisher",
      "first-page": "1366",
      "journal-title": "Obstet Gynecol",
      "key": "276_CR4",
      "unstructured": "TA College of Obstetricians and Gynecologists Committee on Genetics (2019) Hereditary cancer syndromes and risk assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793. Obstet Gynecol 134:1366–1367. https://doi.org/10.1097/AOG.0000000000003562",
      "volume": "134",
      "year": "2019"
    },
    {
      "DOI": "10.1053/j.seminoncol.2016.10.002",
      "author": "K Offit",
      "doi-asserted-by": "publisher",
      "first-page": "615",
      "journal-title": "Semin Oncol",
      "key": "276_CR5",
      "unstructured": "Offit K (2016) The future of clinical cancer genomics. Semin Oncol 43:615–622. https://doi.org/10.1053/j.seminoncol.2016.10.002",
      "volume": "43",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.2013.49.7388",
      "author": "K Offit",
      "doi-asserted-by": "publisher",
      "first-page": "2743",
      "journal-title": "J Clin Oncol",
      "key": "276_CR6",
      "unstructured": "Offit K, Bradbury A, Storm C et al (2013) Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology. J Clin Oncol 31:2743–2748. https://doi.org/10.1200/JCO.2013.49.7388",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nbt.3322",
      "author": "E Clain",
      "doi-asserted-by": "publisher",
      "first-page": "900",
      "journal-title": "Nat Biotechnol",
      "key": "276_CR7",
      "unstructured": "Clain E, Trosman JR, Douglas MP et al (2015) Availability and payer coverage of BRCA1/2 tests and gene panels. Nat Biotechnol 33:900–902. https://doi.org/10.1038/nbt.3322",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1200/JCO.2013.53.6607",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "2001",
      "journal-title": "J Clin Oncol",
      "key": "276_CR8",
      "unstructured": "Kurian AW, Hare EE, Mills MA et al (2014) Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol 32:2001–2009. https://doi.org/10.1200/JCO.2013.53.6607",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1002/jgc4.1155",
      "author": "LM Amendola",
      "doi-asserted-by": "publisher",
      "first-page": "1208",
      "journal-title": "J Genet Couns",
      "key": "276_CR9",
      "unstructured": "Amendola LM, Hart MR, Bennett RL et al (2019) Insurance coverage does not predict outcomes of genetic testing: the search for meaning in payer decisions for germline cancer tests. J Genet Couns 28:1208–1213. https://doi.org/10.1002/jgc4.1155",
      "volume": "28",
      "year": "2019"
    },
    {
      "DOI": "10.1200/JCO.2016.71.0012",
      "author": "MB Yurgelun",
      "doi-asserted-by": "publisher",
      "first-page": "1086",
      "journal-title": "J Clin Oncol",
      "key": "276_CR10",
      "unstructured": "Yurgelun MB, Kulke MH, Fuchs CS et al (2017) Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol 35:1086–1095. https://doi.org/10.1200/JCO.2016.71.0012",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1001/jamaoncol.2016.5194",
      "author": "R Pearlman",
      "doi-asserted-by": "publisher",
      "first-page": "464",
      "journal-title": "JAMA Oncol",
      "key": "276_CR11",
      "unstructured": "Pearlman R, Frankel WL, Swanson B et al (2017) Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol 3:464–471. https://doi.org/10.1001/jamaoncol.2016.5194",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.1001/jama.2018.13152",
      "author": "J Mersch",
      "doi-asserted-by": "publisher",
      "first-page": "1266",
      "journal-title": "J Am Med Assoc",
      "key": "276_CR12",
      "unstructured": "Mersch J, Brown N, Pirzadeh-Miller S et al (2018) Prevalence of variant reclassification following hereditary cancer genetic testing. J Am Med Assoc 320:1266–1274. https://doi.org/10.1001/jama.2018.13152",
      "volume": "320",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2014.147",
      "author": "H Hampel",
      "doi-asserted-by": "publisher",
      "first-page": "70",
      "journal-title": "Genet Med",
      "key": "276_CR13",
      "unstructured": "Hampel H, Bennett RL, Buchanan A et al (2014) A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med 17:70–87. https://doi.org/10.1038/gim.2014.147",
      "volume": "17",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10555-017-9661-5",
      "author": "SA Leachman",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "journal-title": "Cancer Metastasis Rev",
      "key": "276_CR14",
      "unstructured": "Leachman SA, Lucero OM, Sampson JE et al (2017) Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev 36:77–90. https://doi.org/10.1007/s10555-017-9661-5",
      "volume": "36",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.eururo.2019.06.015",
      "author": "MI Carlo",
      "doi-asserted-by": "publisher",
      "first-page": "754",
      "journal-title": "Eur Urol",
      "key": "276_CR15",
      "unstructured": "Carlo MI, Hakimi AA, Stewart GD et al (2019) Familial kidney cancer: implications of new syndromes and molecular insights. Eur Urol 76:754–764",
      "volume": "76",
      "year": "2019"
    },
    {
      "DOI": "10.1111/joim.12869",
      "author": "A Muth",
      "doi-asserted-by": "crossref",
      "first-page": "187",
      "journal-title": "J Intern Med",
      "key": "276_CR16",
      "unstructured": "Muth A, Crona J, Gimm O et al (2019) Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma. J Intern Med 285:187–204",
      "volume": "285",
      "year": "2019"
    },
    {
      "key": "276_CR17",
      "unstructured": "National Comprehensive Cancer Network. Genetic/Familial High-Risk Assessment: Colorectal (Version 1.2020). https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf. Accessed 19 Dec 2020"
    },
    {
      "DOI": "10.1007/s00432-018-2763-9",
      "author": "S Bonache",
      "doi-asserted-by": "publisher",
      "first-page": "2495",
      "journal-title": "J Cancer Res Clin Oncol",
      "key": "276_CR18",
      "unstructured": "Bonache S, Esteban I, Moles-Fernández A et al (2018) Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings. J Cancer Res Clin Oncol 144:2495–2513. https://doi.org/10.1007/s00432-018-2763-9",
      "volume": "144",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s10549-017-4181-0",
      "author": "B Crawford",
      "doi-asserted-by": "publisher",
      "first-page": "383",
      "journal-title": "Breast Cancer Res Treat",
      "key": "276_CR19",
      "unstructured": "Crawford B, Adams SB, Sittler T et al (2017) Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. Breast Cancer Res Treat 163:383–390. https://doi.org/10.1007/s10549-017-4181-0",
      "volume": "163",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41598-019-55515-x",
      "author": "E Jarhelle",
      "doi-asserted-by": "publisher",
      "first-page": "19986",
      "journal-title": "Sci Rep",
      "key": "276_CR20",
      "unstructured": "Jarhelle E, Riise Stensland HMF, Hansen GÅM et al (2019) Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients. Sci Rep 9:19986. https://doi.org/10.1038/s41598-019-55515-x",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.1136/jmedgenet-2019-106403",
      "author": "J Lerner-Ellis",
      "doi-asserted-by": "publisher",
      "first-page": "380",
      "journal-title": "J Med Genet",
      "key": "276_CR21",
      "unstructured": "Lerner-Ellis J, Sopik V, Wong A et al (2020) Retesting of women who are negative for a BRCA1 and BRCA2 mutation using a 20-gene panel. J Med Genet 57:380–384. https://doi.org/10.1136/jmedgenet-2019-106403",
      "volume": "57",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.ygyno.2015.01.537",
      "author": "LE Minion",
      "doi-asserted-by": "publisher",
      "first-page": "86",
      "journal-title": "Gynecol Oncol",
      "key": "276_CR22",
      "unstructured": "Minion LE, Dolinsky JS, Chase DM et al (2015) Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2. Gynecol Oncol 137:86–92. https://doi.org/10.1016/j.ygyno.2015.01.537",
      "volume": "137",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10549-016-4038-y",
      "author": "O Moran",
      "doi-asserted-by": "publisher",
      "first-page": "135",
      "journal-title": "Breast Cancer Res Treat",
      "key": "276_CR23",
      "unstructured": "Moran O, Nikitina D, Royer R et al (2017) Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel. Breast Cancer Res Treat 161:135–142. https://doi.org/10.1007/s10549-016-4038-y",
      "volume": "161",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s12885-017-3940-y",
      "author": "JS Park",
      "doi-asserted-by": "publisher",
      "first-page": "83",
      "journal-title": "BMC Cancer",
      "key": "276_CR24",
      "unstructured": "Park JS, Lee ST, Nam EJ et al (2018) Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer. BMC Cancer 18:83. https://doi.org/10.1186/s12885-017-3940-y",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1002/ijc.31992",
      "author": "S Schubert",
      "doi-asserted-by": "publisher",
      "first-page": "2683",
      "journal-title": "Int J Cancer",
      "key": "276_CR25",
      "unstructured": "Schubert S, van Luttikhuizen JL, Auber B et al (2019) The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: high frequency of FANCM pathogenic variants. Int J Cancer 144:2683–2694. https://doi.org/10.1002/ijc.31992",
      "volume": "144",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s10689-016-9956-7",
      "author": "S Yadav",
      "doi-asserted-by": "publisher",
      "first-page": "319",
      "journal-title": "Fam Cancer",
      "key": "276_CR26",
      "unstructured": "Yadav S, Reeves A, Campian S et al (2017) Outcomes of retesting BRCA negative patients using multigene panels. Fam Cancer 16:319–328. https://doi.org/10.1007/s10689-016-9956-7",
      "volume": "16",
      "year": "2017"
    },
    {
      "DOI": "10.3343/alm.2020.40.2.148",
      "author": "J Yoo",
      "doi-asserted-by": "publisher",
      "first-page": "148",
      "journal-title": "Ann Lab Med",
      "key": "276_CR27",
      "unstructured": "Yoo J, Lee GD, Kim JH et al (2020) Clinical validity of next-generation sequencing multi-gene panel testing for detecting pathogenic variants in patients with hereditary breast-ovarian cancer syndrome. Ann Lab Med 40:148–154. https://doi.org/10.3343/alm.2020.40.2.148",
      "volume": "40",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41598-019-54517-z",
      "author": "M Dominguez-Valentin",
      "doi-asserted-by": "publisher",
      "first-page": "18555",
      "journal-title": "Sci Rep",
      "key": "276_CR28",
      "unstructured": "Dominguez-Valentin M, Nakken S, Tubeuf H et al (2019) Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing. Sci Rep 9:18555. https://doi.org/10.1038/s41598-019-54517-z",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s10689-016-9934-0",
      "author": "A Rohlin",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Fam Cancer",
      "key": "276_CR29",
      "unstructured": "Rohlin A, Rambech E, Kvist A et al (2017) Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing. Fam Cancer 16:195–203. https://doi.org/10.1007/s10689-016-9934-0",
      "volume": "16",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ygyno.2015.08.006",
      "author": "MK Frey",
      "doi-asserted-by": "publisher",
      "first-page": "211",
      "journal-title": "Gynecol Oncol",
      "key": "276_CR30",
      "unstructured": "Frey MK, Kim SH, Bassett RY et al (2015) Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening. Gynecol Oncol 139:211–215. https://doi.org/10.1016/j.ygyno.2015.08.006",
      "volume": "139",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ajg.2014.435",
      "author": "S Syngal",
      "doi-asserted-by": "publisher",
      "first-page": "223",
      "journal-title": "Am J Gastroenterol",
      "key": "276_CR31",
      "unstructured": "Syngal S, Brand RE, Church JM et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110:223–262. https://doi.org/10.1038/ajg.2014.435",
      "volume": "110",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10689-020-00170-9",
      "author": "B Heald",
      "doi-asserted-by": "publisher",
      "first-page": "223",
      "journal-title": "Fam Cancer",
      "key": "276_CR32",
      "unstructured": "Heald B, Hampel H, Church J et al (2020) Collaborative Group of the Americas on Inherited Gastrointestinal Cancer position statement on multigene panel testing for patients with colorectal cancer and/or polyposis. Fam Cancer 19:223–239. https://doi.org/10.1007/s10689-020-00170-9",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1200/JCO.2015.63.0996",
      "author": "ME Robson",
      "doi-asserted-by": "publisher",
      "first-page": "3660",
      "journal-title": "J Clin Oncol",
      "key": "276_CR33",
      "unstructured": "Robson ME, Bradbury AR, Arun B et al (2015) American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 33:3660–3667. https://doi.org/10.1200/JCO.2015.63.0996",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10689-019-00144-6",
      "author": "MK Ndugga-Kabuye",
      "doi-asserted-by": "publisher",
      "first-page": "465",
      "journal-title": "Fam Cancer",
      "key": "276_CR34",
      "unstructured": "Ndugga-Kabuye MK, Issaka RB (2019) Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European. Fam Cancer 18:465–469. https://doi.org/10.1007/s10689-019-00144-6",
      "volume": "18",
      "year": "2019"
    },
    {
      "key": "276_CR35",
      "unstructured": "National Comprehensive Cancer Network. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version 1.2022). https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf. Accessed 28 Aug 2021"
    },
    {
      "DOI": "10.1007/s10897-016-0001-7",
      "author": "KG Flores",
      "doi-asserted-by": "publisher",
      "first-page": "480",
      "journal-title": "J Genet Couns",
      "key": "276_CR36",
      "unstructured": "Flores KG, Steffen LE, McLouth CJ et al (2017) Factors associated with interest in gene-panel testing and risk communication preferences in women from BRCA1/2 negative families. J Genet Couns 26:480–490. https://doi.org/10.1007/s10897-016-0001-7",
      "volume": "26",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10897-018-0241-9",
      "author": "SE Chadwell",
      "doi-asserted-by": "publisher",
      "first-page": "1210",
      "journal-title": "J Genet Couns",
      "key": "276_CR37",
      "unstructured": "Chadwell SE, He H, Knapke S et al (2018) Factors influencing clinical follow-up for patients with a personal history of breast and ovarian cancer and previous uninformative BRCA1 and BRCA2 testing. J Genet Couns 27:1210–1219. https://doi.org/10.1007/s10897-018-0241-9",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.1002/jgc4.1173",
      "author": "L Sawyer",
      "doi-asserted-by": "publisher",
      "first-page": "1198",
      "journal-title": "J Genet Couns",
      "key": "276_CR38",
      "unstructured": "Sawyer L, Creswick H, Lewandowski R, Quillin J (2019) Recontacting patients for multigene panel testing in hereditary cancer: efficacy and insights. J Genet Couns 28:1198–1207. https://doi.org/10.1002/jgc4.1173",
      "volume": "28",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41431-018-0285-1",
      "author": "D Carrieri",
      "doi-asserted-by": "publisher",
      "first-page": "169",
      "journal-title": "Eur J Hum Genet",
      "key": "276_CR39",
      "unstructured": "Carrieri D, Howard HC, Benjamin C et al (2019) Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics. Eur J Hum Genet 27:169–182. https://doi.org/10.1038/s41431-018-0285-1",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s12687-017-0322-8",
      "author": "B Vicuña",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "journal-title": "J Commun Genet",
      "key": "276_CR40",
      "unstructured": "Vicuña B, Delaney HD, Flores KG et al (2018) Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families. J Commun Genet 9:81–92. https://doi.org/10.1007/s12687-017-0322-8",
      "volume": "9",
      "year": "2018"
    }
  ],
  "reference-count": 40,
  "references-count": 40,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-021-00276-8"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Outcomes of retesting in patients with previously uninformative cancer genetics evaluations"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "21"
}